Ten critically ill patients underwent this prospective study to assess the reliability of the continuous thermodilution versus transoesophageal Doppler techniques in the determination of continuous cardiac output (CO) and systemic vascular resistance (SVR). A total of 145 pairs of CO and SVR measurements were obtained by both a pulmonary artery catheter with a heated filament and a transoesophageal Doppler apparatus (ODM II). Total CO ranged from 2.4 and 13 l.min -1 ; the bias of all measurements was 0.01±0.48 l.min -1 , and the 95% confidence limits (mean difference±2 SD) were 0.97/0.96 l.min -1 . Total SVR ranged from 309 and 2643 dyn.s.cm -5 ; the bias of all measurements was 18±127 dyn.s.cm -5 , and the 95%, confidence limits were 272/236 dyn.s.cm -5 . Transoesophageal Doppler accurately measures continuous CO and SVR in critically ill patients. It should be viewed as complementary to pulmonary catheterization.
A wide variety of methods (invasive and noninvasive) for assessing cardiac output have been developed 1, 2 . At the moment, the most widely accepted technique for measuring cardiac output in clinical settings is the thermodilution method 3 . A recently introduced continuous cardiac output monitoring device based on the thermodilution technique has produced promising results 4, 5 . Evaluation of cardiac output is one of the most important benefits of pulmonary artery catheterization because by calculating derived variables, such as systemic vascular resistance values, information can be obtained on heart function and vascular status. A new method, transoesophageal Doppler ultrasound evaluation of descending aortic blood flow, is an alternative, relatively non-invasive and continuous method for measuring haemodynamic parameters 6 . Close correlations have been found between transoesophageal Doppler and standard thermodilution techniques for cardiac output measurement 7 . An index of systemic vascular resistance can be obtained non-invasively by dividing the mean arterial blood pressure by the minute distance 8 .
The aim of the present study was to assess the reliability of continuous thermodilution versus transoesophageal Doppler in determining continuous cardiac output and systemic vascular resistance in critically ill patients.
MATERIALS AND METHODS
Patients. After obtaining institutional approval and informed consent, we prospectively studied 10 patients admitted to our intensive care unit. In all patients, invasive haemodynamic monitoring using a pulmonary artery catheter was considered necessary to follow the effect of treatment. Patients with known oesophageal or gross clotting disorders were excluded.
Thermodilution technique. A pulmonary artery catheter (PAC) (Continuous Cardiac Output Thermodilution Catheter, PA3 H-8F, Baxter Edwards Critical-Care, Irvine, CA) was used. The catheter is equipped with a 10cm thermal filament located close to the injection port (15 to 25 cm from the tip). Low heat energy is transmitted into the surrounding blood, according to a pseudorandom binary sequence 9 . The heat signal in the blood is processed over time, and a thermodilution curve is reconstructed from the temperature changes detected from the pseudorandom heat impulses. A computer system (Vigilance, Baxter Edwards Critical-Care) measures cardiac output automatically. However, the system does not provide instantaneous (continuous) cardiac output, but rather averages measurements over a three-minute period; i.e., the system produces a continuously updated (every 50 seconds), time-averaged, cardiac output value. The theoretical background and detailed technique have been reported elsewhere 9 . Both the safety and accuracy of this system have been shown in animal and human experiment.
Transoesophageal Doppler technique. The machine used for the study was the Oesophageal Doppler Machine (ODM II) (Abbott Lab, U.S.A.). An oesophageal probe with a transducer emitting 4 Mhz continuous-wave Doppler ultrasound in a large nasogastric tube 6 mm in diameter was used. The transducer was lubricated with gel to aid passage through the pharynx. It was inserted through the nose to a depth of 35 to 40 cm from the teeth and connected to a spectral analyzer system with a monitor displaying flow velocity waveforms. It was angled to 45°, so that the cos q term in the Doppler equation was 0.71 and for a 5° angular shift in probe orientation the largest error in flow measurement was no greater than 5%. The probe was rotated as needed to obtain blood flow in the midstream of the descending thoracic aorta; this was denoted by a sharp, well-defined waveform seen on the monitor and by a crisp sound heard through the loudspeaker. A continuous visual display of velocity-time waveforms and derived variables was provided by the monitor. Stroke distance (SD) is the systolic velocity-time integral (the area of the waveform) and the length a column of blood travels along the aorta with each ventricular stroke. The product of aortic cross-sectional area (CSA) by SD is the volume of each ventricular stroke, or stroke volume (SV). The minute distance (MD) is the product of SD by heart rate, a linear measure of cardiac output. A nomogram of age, height and weight was used to estimate aortic CSA 11 .
Measured Variables and Data Points. Simultaneous paired measurements of cardiac output and systemic vascular resistance by the two techniques were obtained by two independent investigators, each of whom used one of the techniques and was unaware of the findings obtained by the other. Measurements were done while the patients were haemodynamically stable. Measurements were carried out six times a day (on a routine basis) and whenever necessary for clinical reasons (e.g., a mean arterial blood pressure of <60 mmHg). Systemic blood pressure (BP) was obtained via a pressure transducer connected to a radial or femoral arterial catheter. The central venous pressure (CVP) reading was made at endexpiration with the zero reference point taken at the right atrial level. Systemic vascular resistance (SVR) was calculated from both PAC (SVR) and ODM II (ISVR) measurements. SVR was calculated by dividing (mean BP-CVPI) by cardiac output, and ISVR by dividing mean BP by minute distance. As previously reported, the values thus obtained were multiplied by 10,000 to achieve numerical equivalents to the systemic vascular resistance value derived invasively 12 . Central venous pressure (CVP) measurement was not used to calculate this non-invasive index of systemic vascular resistance. However, changes in CVP are likely to be small in comparison with changes in mean arterial pressure.
Statistics. The Bland and Altman method was used to compare derived continuous cardiac output and systemic vascular resistance values 13 . The bias (mean difference between the two methods) was used. The bias represents the systematic error between two (monitoring) methods. Precision (SD of the bias) is representative of the random error or variability between the different techniques. Mean difference ±2 SD is known as the "limits of agreement". The relative error (expressed in degrees %) was defined as 100 x [cardiac output PAC minus cardiac output ODM II]/cardiac output PAC).
RESULTS
A total of 10 patients participated in the study, nine men and one woman with a mean age of 66±15 years. Four had septic shock, three had multiple injuries, and one each had drug overdosage, acute pulmonary oedema, and pulmonary embolism. The mean Acute Physiology and Chronic Health Evaluation (APACHE) II score 14 at entry into the study was 28±6. A total of 145 pairs of cardiac output measurements and calculated systemic vascular resistance values were obtained.
Cardiac output measurements. Total cardiac output ranged from 2.4 to 13 l/min. The bias of all measurements was -0.01±0.48 l/min; the 95% confidence limits (mean difference±2 SD) were -0.97/0.96 l/min (Figure 1) . The relative error for all measurements was -0.1±6.6%.
Calculated systemic vascular resistance. Total systemic vascular resistance ranged from 309 to 2643 dyn.s.cm -5 . The bias of all measurements was 18±127 dyn.s.cm -5 ; the 95% confidence limits (mean difference ±2 SD) were 272/236 dyn.s.cm -5 (Figure 2) . The relative error for all measurements was -1±14 %.
DISCUSSION
Monitoring cardiac output changes using the oesophageal approach requires that a number of assumptions be valid: the assumed 45° angle between the ultrasound beam and the direction of blood flow must be accurate and must remain fixed despite, for example, mechanical ventilation; the aortic crosssectional area must remain constant throughout systole despite changes in blood pressure and/or cardiac output; and the proportion of left ventricular output that travels down the descending thoracic aorta must remain constant. Moreover, potential imperfect accuracy of the nomogram (aortic crosssectional area) introduces another limitation. Probe placement at 35 to 40 cm from the teeth is at the level of the 5th-6th thoracic vertebra, where the oesophagus runs parallel to the descending aorta 15 . Accurate placement at this level is mandatory because the signal can be detected both above and below this level, where 45° angulation cannot be assumed. Aortic diameter during the cardiac cycle increases by less than 1 mm, with most of this change occurring during early systole and the diameter remaining almost constant thereafter 16 . Regional blood flow distribution to the limbs, heart, and other organs has been delineated in an earlier study, which demonstrated a constant relationship between descending aortic blood flow and total blood flow during normal, high, and low output states 17 . Despite the many assumptions inherent in transoesophageal Doppler cardiac output determination, a good correlation has been reported between this technique and standard thermodilution 7 . Our study provides further evidence of this correlation. Ours is the first study to compare calculation of derived variables, such as systemic vascular resistance, obtained by continuous thermodilution and transoesophageal Doppler. We found that the transoesophageal Doppler allowed assessment of systemic vascular resistance, providing a general trend rather than an absolute value.
Systemic vascular resistance is a calculated parameter that is not directly measured by available methods. Nevertheless, it is widely used to characterize the haemodynamic state (e.g., in septic shock).
Although we obtained a cardiac output value using the Doppler technique, we derived systemic vascular resistance from mean distance rather than from cardiac output, first, because this approach has been previously described 12 and, second, in order to limit the dependence between cardiac output and systemic vascular resistance values. Cardiac output was not measured but calculated from a nomogram.
The oesophageal Doppler device used in our study provides a continuous display of the velocity waveforms of blood travelling down the descending thoracic aorta. This allows us to check proper probe orientation, signal quality, and software computations, a significant advantage over earlier devices. Doppler cardiac output measurement requires determination of the aortic cross-sectional area. The ODM II determines the aortic cross-sectional area using a nomogram based on age, height, and weight of the patient 11 . Data on age-related (and to a lesser extent the body surface area-related) increases in aortic diameter have been reported [18] [19] . An advantage of this approach is that it does not require an independent ultrasound measurement of aortic diameter. Thus, it can be used easily, even by examiners who do not have training in ultrasonography.
Transoesophageal Doppler is a viable and reliable technique for measuring cardiac output in critically ill patients. Our data are consistent with studies that compared standard (bolus) to continuous thermodilution cardiac output measurements 5 . Moreover, because the transoesophageal method used in our study provides instantaneous, beat-by-beat data, it detects instantaneous alterations in cardiac output.
Patel et al demonstrated that it detected cardiac output changes within the first minute following an increase in PEEP 20 . The continuous cardiac output thermodilution catheter does not provide instantaneous cardiac output, but rather averages measurements over a three-minute period.
This study was not designed to analyse left ventricular filling. However, transoesophageal Doppler provides information on haemodynamic parameters other than cardiac output. Singer et al demonstrated that Doppler measurement of descending aortic blood flow could be used to optimize left ventricular filling 21 .
Transoesophageal Doppler should be viewed as complementary to pulmonary catheterization. A survey of pulmonary artery catheter use in ICUs in Great Britain confirmed that a clinical judgement of haemodynamic instability was the main indication for insertion 22 . However, at the stage of haemodynamic instability organ dysfunction is sometimes already established. Routine pulmonary artery catheterization of all ICU patients would not be feasible, costeffective, or medically appropriate. In addition, this procedure has well-documented complications [23] [24] . It is difficult for physicians to differentiate patients -who can be managed safely without right heart catheterization from those who would benefit from 36 TRANSOESOPHAGEAL DOPPLER VS CONTINUOUS THERMODILUTION Anaesthesia and Intensive Care, Vol. 27, No. 1, February 1999 the information provided by this procedure. It follows that a reappraisal of our approach to monitoring critically ill patients is in order. We suggest that transoesophageal Doppler deserves to be used early to obtain haemodynamic information and to guide therapeutic decisions.
